Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 214683, 8 pages
http://dx.doi.org/10.1155/2015/214683
Research Article

Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients

Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China

Received 8 May 2014; Revised 25 October 2014; Accepted 28 October 2014

Academic Editor: James C. C. Wei

Copyright © 2015 Yu Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yu Wei, Xiaoxun Sun, Minhui Hua, Wenfeng Tan, Fang Wang, and Miaojia Zhang, “Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients,” BioMed Research International, vol. 2015, Article ID 214683, 8 pages, 2015. https://doi.org/10.1155/2015/214683.